Business Wire

Lookout Survey Reveals Critical Gaps in Security Leaders' Confidence and the Actual Vulnerability of Their Organizations

Share

Independent Data Confirms Concerning Disconnect Between Belief and Reality When It Comes to Mobile Cybersecurity Preparedness

A new global survey by Lookout, Inc., the leader in mobile endpoint security, today unveiled concerning insights into the state of mobile cybersecurity preparedness, revealing a significant gap between security leaders' confidence and the actual vulnerability of their organizations. The survey of more than 700 security leaders globally exposes a pervasive overconfidence in employees' ability to detect modern mobile-centric threats, leaving businesses significantly more exposed than they realize.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250710838048/en/

The survey's most critical insights include:

  • 58% of companies have experienced incidents due to executive impersonation scams via text or voice, highlighting the severe impact of sophisticated social engineering tactics.
  • 77% of respondents have experienced one or more mobile phishing attacks in the past six months, underscoring the ubiquity of these threats.
  • 51% admit to having inconsistent visibility of social engineering attempts, creating massive security blind spots.

Despite these alarming statistics, the survey revealed pervasive overconfidence: 96% of leaders are confident their employees can spot a phishing attempt that comes via their mobile devices. Yet, over half reported incidents where employees fell victim to executive impersonation scams, leading to financial loss or sensitive data exposure. Furthermore, even with widespread security training efforts, "lack of training" remains the top reason cited for employees clicking suspicious links, suggesting current education may not be keeping pace with the rapidly evolving modern threat landscape.

"Today's threat actors are increasingly sophisticated, and they understand that mobile endpoints have historically been an afterthought in many enterprise security strategies," said Jim Dolce, CEO of Lookout. "This survey clearly demonstrates that this oversight is creating a dangerous vulnerability. Attackers are aggressively targeting employees on their iOS and Android devices, using highly effective social engineering tactics delivered via SMS, voice, and messaging apps to compromise credentials and gain quiet access to enterprise data."

These findings highlight core issues:

  • A dangerous overconfidence gap: Organizations feel ready for threats but are demonstrably underprepared, leading to successful attacks.
  • Inadequate visibility: Traditional security solutions often lack visibility into mobile-centric social engineering attempts, meaning many manipulative efforts go unnoticed until it's too late.
  • Outdated training: Security awareness training isn't evolving fast enough to truly prepare employees for today's sophisticated, mobile-focused threats.

To address these pressing challenges, Lookout emphasizes a multi-faceted approach to secure the "front line" – employees and their mobile devices. This includes:

  • Implementing an AI-first social engineering and human risk solution: This provides baseline protection against today’s Modern Kill Chain.
  • Integrating Mobile Endpoint Detection and Response (EDR): Gaining strategic mobile security data points, such as vulnerable assets and web traffic analysis, by integrating EDR into existing SIEM, SOAR, EDR, or XDR solutions.
  • Sophisticated and ongoing security awareness training: Training specifically designed for mobile-centric threats, including simulated phishing and social engineering exercises that reflect current malicious tactics, fostering a culture of vigilance and easy, judgment-free reporting.

About the Survey

The data presented in this report is sourced from the independent research company Censuswide, which conducted the survey in June 2025. More than 700 security leaders globally were polled across various industries. Censuswide is a member of the British Polling Council and abides by and employs members of the Market Research Society and follows the MRS code of conduct and ESOMAR principles.

About Lookout

Lookout, Inc. is a globally recognized cybersecurity leader delivering advanced protection for the most vulnerable element of any enterprise security strategy — human error and manipulation. Cloud-native by design, the Lookout platform offers rapid, scalable deployment and simplified security operations, defending the frontline of human-centric attacks—the mobile device.

Attackers now target the human element more than ever, with mobile devices providing the most direct path to their victims. Using social engineering techniques that exploit basic human instincts like trust, curiosity, and urgency, they deceive users into revealing sensitive credentials, allowing them to slip past legacy security solutions.

Lookout Endpoint Detection and Response (EDR) continuously monitors mobile endpoints for signs of human-centric attacks, as well as traditional malware, software vulnerabilities, and other anomalous activity. It uses advanced threat detection techniques, including artificial intelligence (AI) and behavioral analysis, to identify threats before they escalate across the enterprise.

Learn more at www.lookout.com and follow us on the Lookout Blog, LinkedIn, and X

© 2025 Lookout, Inc. LOOKOUT®, the Lookout Shield Design®, LOOKOUT with Shield Design® and the Lookout multi-color/multi-shaded Wingspan Design® are registered trademarks of Lookout, Inc. in the United States and other countries. DAY OF SHECURITY®, LOOKOUT MOBILE SECURITY®, and POWERED BY LOOKOUT® are registered trademarks of Lookout, Inc. in the United States. Lookout, Inc. maintains common law trademark rights in EVERYTHING IS OK, PROTECTED BY LOOKOUT, CIPHERCLOUD, and the 4 Bar Shield Design.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250710838048/en/

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Daiichi Sankyo Announces the Initiation of the Development of Oral Triple Combination Lipid-Lowering Tablets to Support the Management of LDL-C30.8.2025 18:00:00 CEST | Press release

Initiation of the development of new oral triple combination tablets, aimed at improving adherence and outcomes in low-density lipoprotein cholesterol (LDL-C) management. Recent findings from MILOS and SANTORINI registries presented at ESC Congress 2025, highlight ongoing challenges in accurately assessing cardiovascular (CV) risk and helping patients reach LDL-C targets.1-5 Furthermore, data from a four-country cohort of the MILOS study support the real-world effectiveness and safety of bempedoic acid in both sexes.6 Simulation using SANTORINI data reveals the potential of improved LDL-C goal attainment with tailored oral combination therapy of statins, ezetimibe and bempedoic acid, in line with the latest 2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias.7,8 Daiichi Sankyo has a long-standing commitment to easing treatment of cardiovascular disease (CVD) and exploring new treatment options that improve CVD outcomes and treatment adherence. Daiich

Alnylam to Advance Zilebesiran into Global Phase 3 Cardiovascular Outcomes Trial30.8.2025 16:30:00 CEST | Press release

- Phase 3 Trial Informed by KARDIA-3 Phase 2 Study Results Presented as a Late-Breaking Abstract at the European Society of Cardiology Congress 2025 -- Zilebesiran Demonstrated Clinically Meaningful Reductions in Office Systolic Blood Pressure in Patients with Uncontrolled Hypertension and High Cardiovascular Risk at Month 3 Primary Endpoint, with Continuous Control Through Month 6 -- Zilebesiran Displayed Encouraging Safety When Combined with Two or More Antihypertensives -- Results Support Biannual Dosing Regimen and Inform Phase 3 Trial Design: Trial Expected to Initiate by Year-End 2025 -- Alnylam to Host Webcast Investor Event on August 30, 2025, at 1:00 pm ET (7:00 pm CEST) - Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced plans to initiate a Phase 3 cardiovascular outcomes trial (CVOT) to evaluate the potential of zilebesiran to reduce the risk of major adverse cardiovascular events. This decision is informed by results from t

Andersen Consulting styrker sine kompetencer inden for virksomhedstransformation med Fabric29.8.2025 17:01:00 CEST | Pressemeddelelse

Andersen Consulting udvider sin platform gennem en samarbejdsaftale med Fabric, der er et strategisk designfirma, der arbejder med organisationer for at integrere bæredygtighed, forsyningskæder og menneske-centreret innovation på tværs af kultur og drift. Fabric blev grundlagt i Japan i 2021 og arbejder sammen med virksomheder og globale brands om at skabe regenerative forretningsmodeller sammen samt bæredygtige brandstrategier og fremtidssikrede produkter. Ved hjælp af strategiske designmetoder og designfilosofi skaber virksomheden indsigtsbaseret transformation på tværs af forsyningskæder, brand og HR. Fabric er kendt for sin systemtænkning og sit engagement i social og miljømæssig bæredygtighed og fremmer desuden digitale transformationsinitiativer, der integrerer bæredygtighed, humankapital og AI. "Fabric er skabt for at hjælpe virksomheder med at blomstre gennem regenerative relationer til mennesker, samfund og forbundne, levende systemer," sagde James Hollow, der er grundlægger a

Andersen Consulting tilføjer samarbejdsfirmaet Skribble29.8.2025 16:28:00 CEST | Pressemeddelelse

Andersen Consulting udvider sine kompetencer inden for strategi og virksomhedstransformation gennem en samarbejdsaftale med Skribble, der er et rådgivningsfirma inden for digital teknologi og branding, der hjælper virksomheder i Sydøstasien med innovation og driftsmæssig transformation. Skribble, der blev etableret i 2020, tilbyder en bred vifte af services, herunder brand- og kommunikationsstrategi, digital markedsføring, specialudvikling af teknologi, forandringsledelse og platformsløsninger. Virksomheden hjælper organisationer inden for ejendomme, forbrugsvarer, bankverdenen og den offentlige sektor ved at sikre, at strategi og eksekvering er tæt forbundet – med henblik på at levere integrerede løsninger inden for brand, performance og teknologi. Skribbe fokuserer på procesoptimering har kreative og tekniske kompetencer, der hjælper kunderne med at skabe forandringer og vækst. "Hos Skribble arbejder vi på at omsætte kreativ energi til strategiske resultater," sagde Chan Leong, CEO f

BeOne Medicines Announces Positive Topline Results for Sonrotoclax in Relapsed or Refractory Mantle Cell Lymphoma (MCL)29.8.2025 12:00:00 CEST | Press release

Study met its primary endpoint of overall response rate (ORR), demonstrating clinically meaningful responses in rare B-cell lymphoma with high unmet needBeOne to submit data to global regulatory authorities for their review and potential approval BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced positive topline results from a Phase 1/2 study (BGB-11417-201) of sonrotoclax, a next-generation and potentially best-in-class investigational BCL2 inhibitor, in adult patients with relapsed/refractory (R/R) mantle cell lymphoma (MCL), following treatment with a Bruton’s tyrosine kinase inhibitor (BTKi) and anti-CD20 therapy. BeOne plans to present the full data at an upcoming medical meeting. “For people with relapsed or refractory mantle cell lymphoma, the disease is aggressive, the treatment landscape fragmented, and the outcomes unacceptably poor. These topline results for sonrotoclax underscore its potential to deliver meaningful and

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye